Advancements in Lower Anogenital and Urinary Tract Pathology

Discover the latest developments in the pathology of the lower anogenital and urinary tracts, including the identification of relevant genes, improved immunohistochemical markers, and the detection of human papillomavirus (HPV) using RNA in situ hybridization. This comprehensive guide covers new entities, diagnostic challenges, and treatment options, including immunotherapy.

Target Audience

Practicing academic and community pathologists, as well as pathologists-in-training, will benefit from this educational activity.

Learning Objectives

Upon completion of this educational activity, learners will be able to:

• Discuss novel recently described human papilloma virus (HPV)-associated and HPV-independent neoplasms of the lower genital tract.
• Present a modern viewpoint for grading prostatic carcinoma.
• Address pitfalls in diagnosing urothelial neoplasms versus those from adjoining sites, including treatment-related pitfalls.
• Consider mimickers of common neoplasms of the anogenital and urothelial tracts.
• Establish a systematic approach to diagnostic challenges in cytology.

Program Items

Items included in the purchase of this course:

• Male Genital Tract Infernos – Sara E. Wobker MD, MPH
• Lower Gastrointestinal Tract Infernos – Elizabeth Montgomery, MD
• Female Genital Tract Infernos – Andre Pinto, MD
• Cytologic Infernos – Christopher J. VandenBussche, MD
• Male Genital Tract Mirages – Sara E. Wobker MD, MPH
• Lower Gastrointestinal Tract Mirages – Elizabeth Montgomery, MD
• Female Genital Tract Mirages – Andre Pinto, MD
• Cytologic Mirages – Christopher J. VandenBussche, MD

Original release date: May 16, 2023. Access to this course expires on April 11, 2026.